Volume | 350,086 |
|
|||||
News | - | ||||||
Day High | 48.185 | Low High |
|||||
Day Low | 45.596 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Praxis Precision Medicines Inc | PRAX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
46.59 | 45.596 | 48.185 | 46.89 | 46.59 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
6,214 | 350,086 | $ 46.85 | $ 16,401,378 | - | 12.45 - 67.21 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:54:56 | 1 | $ 45.98 | USD |
Praxis Precision Medicines Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
620.75M | 13.24M | - | 2.45M | -123.28M | -9.31 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Praxis Precision Medicines News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRAX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 53.59 | 56.58 | 45.596 | 51.09 | 170,058 | -6.70 | -12.50% |
1 Month | 53.76 | 67.21 | 45.596 | 56.80 | 335,191 | -6.87 | -12.78% |
3 Months | 36.99 | 67.21 | 36.01 | 53.14 | 192,781 | 9.90 | 26.76% |
6 Months | 18.45 | 67.21 | 13.005 | 33.04 | 246,096 | 28.44 | 154.15% |
1 Year | 15.90 | 67.21 | 12.45 | 21.48 | 629,035 | 30.99 | 194.91% |
3 Years | 405.60 | 489.00 | 11.85 | 61.69 | 783,508 | -358.71 | -88.44% |
5 Years | 408.15 | 914.2575 | 11.85 | 86.16 | 704,469 | -361.26 | -88.51% |
Praxis Precision Medicines Description
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others. |